Members |
acceptabilityId |
2nd |
Acceptable (foundation metadata concept) |
2nd HiB and DTP vaccine given |
Preferred (foundation metadata concept) |
2nd HiB and DTP vaccine given (situation) |
Preferred (foundation metadata concept) |
2nd Hib and DTP vaccine given |
Preferred (foundation metadata concept) |
2nd Japanese encephalitis vaccination |
Preferred (foundation metadata concept) |
2nd Japanese encephalitis vaccination |
Preferred (foundation metadata concept) |
2nd Japanese encephalitis vaccination (procedure) |
Preferred (foundation metadata concept) |
2nd Japanese encephalitis vaccination (procedure) |
Preferred (foundation metadata concept) |
2nd floor |
Acceptable (foundation metadata concept) |
2nd heart sound split |
Acceptable (foundation metadata concept) |
2nd hepatitis A junior vaccination |
Acceptable (foundation metadata concept) |
2nd left lumbar vein |
Acceptable (foundation metadata concept) |
2nd right lumbar vein |
Acceptable (foundation metadata concept) |
2nd specimen |
Acceptable (foundation metadata concept) |
2nd stage of labor length |
Preferred (foundation metadata concept) |
2nd stage of labor length |
Acceptable (foundation metadata concept) |
2nd stage of labour length (observable entity) |
Preferred (foundation metadata concept) |
2nd trimester |
Acceptable (foundation metadata concept) |
2p partial trisomy syndrome |
Preferred (foundation metadata concept) |
2p partial trisomy syndrome (disorder) |
Preferred (foundation metadata concept) |
2p13.2 microdeletion syndrome |
Preferred (foundation metadata concept) |
2p13.2 microdeletion syndrome (disorder) |
Preferred (foundation metadata concept) |
2p15p16.1 microdeletion syndrome |
Preferred (foundation metadata concept) |
2p15p16.1 microdeletion syndrome (disorder) |
Preferred (foundation metadata concept) |
2p21 microdeletion syndrome |
Preferred (foundation metadata concept) |
2p21 microdeletion syndrome (disorder) |
Preferred (foundation metadata concept) |
2p21 microdeletion syndrome without cystinuria |
Preferred (foundation metadata concept) |
2p21 microdeletion syndrome without cystinuria (disorder) |
Preferred (foundation metadata concept) |
2q partial trisomy syndrome |
Preferred (foundation metadata concept) |
2q partial trisomy syndrome (disorder) |
Preferred (foundation metadata concept) |
2q23.1 microdeletion syndrome |
Preferred (foundation metadata concept) |
2q23.1 microdeletion syndrome (disorder) |
Preferred (foundation metadata concept) |
2q23.1 microduplication syndrome |
Preferred (foundation metadata concept) |
2q23.1 microduplication syndrome (disorder) |
Preferred (foundation metadata concept) |
2q24 microdeletion syndrome |
Preferred (foundation metadata concept) |
2q24 microdeletion syndrome (disorder) |
Preferred (foundation metadata concept) |
2q31.1 microdeletion syndrome |
Preferred (foundation metadata concept) |
2q31.1 microdeletion syndrome (disorder) |
Preferred (foundation metadata concept) |
2q32q33 microdeletion syndrome |
Preferred (foundation metadata concept) |
2q32q33 microdeletion syndrome (disorder) |
Preferred (foundation metadata concept) |
2q33.1 microdeletion syndrome |
Preferred (foundation metadata concept) |
2q33.1 microdeletion syndrome (disorder) |
Preferred (foundation metadata concept) |
2q37 deletion syndrome |
Acceptable (foundation metadata concept) |
2x normal saline 1.8% infusion solution bag |
Acceptable (foundation metadata concept) |
2x/wk |
Acceptable (foundation metadata concept) |
3 |
Preferred (foundation metadata concept) |
3 |
Preferred (foundation metadata concept) |
3 |
Acceptable (foundation metadata concept) |
3 (qualifier value) |
Preferred (foundation metadata concept) |
3 Buck shot |
Preferred (foundation metadata concept) |
3 Buck shot, device |
Acceptable (foundation metadata concept) |
3 Buck shot, device (qualifier value) |
Preferred (foundation metadata concept) |
3 alpha hydroxycholanic acid |
Acceptable (foundation metadata concept) |
3 alpha, 7 alpha, 12 alpha, Trihydroxycholanic acid |
Acceptable (foundation metadata concept) |
3 alpha, 7 beta dihydroxy-5 beta cholanic acid |
Acceptable (foundation metadata concept) |
3 alpha,12 alpha, dihydroxycholanic acid |
Acceptable (foundation metadata concept) |
3 alpha,7 alpha, dihydroxycholanic acid |
Acceptable (foundation metadata concept) |
3 beta-HSD deficiency |
Acceptable (foundation metadata concept) |
3 beta-Hydroxysteroid dehydrogenase deficiency |
Preferred (foundation metadata concept) |
3 beta-Hydroxysteroid dehydrogenase deficiency (disorder) |
Preferred (foundation metadata concept) |
3 day faecal fat estimation (& level) (procedure) |
Preferred (foundation metadata concept) |
3 day faecal fat estimation (& level) (procedure) |
Preferred (foundation metadata concept) |
3 day fecal fat estimation |
Preferred (foundation metadata concept) |
3 day fecal fat estimation |
Acceptable (foundation metadata concept) |
3 day fecal fat estimation (& level) |
Preferred (foundation metadata concept) |
3 day fecal fat estimation (& level) |
Preferred (foundation metadata concept) |
3 day fecal fat estimation (procedure) |
Preferred (foundation metadata concept) |
3 female babies |
Acceptable (foundation metadata concept) |
3 hourly |
Acceptable (foundation metadata concept) |
3 hours post-dose |
Preferred (foundation metadata concept) |
3 hours post-dose (qualifier value) |
Preferred (foundation metadata concept) |
3 lead electrocardiographic monitoring |
Preferred (foundation metadata concept) |
3 lead electrocardiographic monitoring (procedure) |
Preferred (foundation metadata concept) |
3 level of presenting part in relation to ischial spines |
Preferred (foundation metadata concept) |
3 level of presenting part in relation to ischial spines (finding) |
Preferred (foundation metadata concept) |
3 male babies |
Acceptable (foundation metadata concept) |
3 methoxy 4 hydroxy phenethylamine |
Acceptable (foundation metadata concept) |
3 methoxy 4 hydroxyphenethylamine |
Acceptable (foundation metadata concept) |
3 methoxy 4 hydroxyphenylethylamine |
Acceptable (foundation metadata concept) |
3 methoxydopamine |
Acceptable (foundation metadata concept) |
3 o'clock position |
Preferred (foundation metadata concept) |
3 o'clock position (qualifier value) |
Preferred (foundation metadata concept) |
3 o'clock position on mammogram |
Preferred (foundation metadata concept) |
3 o'clock position on mammogram (finding) |
Preferred (foundation metadata concept) |
3 part fracture |
Preferred (foundation metadata concept) |
3 part fracture (morphologic abnormality) |
Preferred (foundation metadata concept) |
3 pin head fixation device |
Preferred (foundation metadata concept) |
3 pin head fixation device (physical object) |
Preferred (foundation metadata concept) |
3 point swing through gait |
Preferred (foundation metadata concept) |
3 point swing through gait (finding) |
Preferred (foundation metadata concept) |
3 point swing to gait |
Preferred (foundation metadata concept) |
3 point swing to gait (finding) |
Preferred (foundation metadata concept) |
3 serotype |
Preferred (foundation metadata concept) |
3 serotype (qualifier value) |
Preferred (foundation metadata concept) |
3 serotypes |
Acceptable (foundation metadata concept) |
3 times a day, before meals |
Acceptable (foundation metadata concept) |
3 times a day, with meals |
Acceptable (foundation metadata concept) |
3 to 4 times a day |
Acceptable (foundation metadata concept) |
3 toed sloth |
Acceptable (foundation metadata concept) |
3% Acetic acid |
Preferred (foundation metadata concept) |
3% Acetic acid (substance) |
Preferred (foundation metadata concept) |